Exelon prices $900 M deal of 3.25% convertible senior notes due 2029

Exelon Corporation (Nasdaq: EXC) has priced an offering of US$900 million aggregate principal amount of 3.25% convertible senior notes due 2029 via a private placement under the Securities Act. The company granted the initial purchasers an option to purchase up to an additional US$100 million of notes within 13 days of issuance. The sale is expected to close on December 4, 2025, subject to customary closing conditions. Net proceeds from the offering are expected to be approximately US$888.8 million — or up to US$987.5 million if the additional-notes option is exercised in full — before other offering expenses. Exelon intends to use the proceeds for debt repayment or refinancing and general corporate purposes. The notes are senior unsecured obligations that will mature on March 15, 2029 (unless earlier converted or repurchased). Interest is fixed at 3.25% per year, payable semi‑annually in arrears on March 15 and September 15, beginning September 15, 2026. Conversion terms: initially, each US$1,000 of notes converts into 17.5093 shares of Exelon common stock — equivalent to an initial conversion price of about US$57.11 per share, roughly a 25% premium over Exelon’s share price on December 1, 2025. Prior to December 15, 2028, conversion is allowed only under certain conditions; after that date, holders may convert at any time before maturity. Upon conversion, Exelon may settle by paying cash up to the principal amount, and for any excess, paying or delivering common stock or a mix of cash and stock, at its discretion. In the event of a “fundamental change” (per the indenture), holders may require Exelon to repurchase their notes at 100% of principal plus accrued interest. Under certain circumstances, Exelon may also be required to increase the conversion rate for conversions tied to such a change. #Exelon #ConvertibleNotes #CorporateFinance #DebtRefinancing #SlimScan #GrowthStocks #CANSLIM